Piramal Pharma US FDA Sellersville Inspection Closed

Key Development

Piramal Pharma Limited has successfully closed the US FDA inspection at its manufacturing facility located in Sellersville, USA. The US Food and Drug Administration (US FDA) has issued an Establishment Inspection Report (EIR) for the facility, formally concluding the inspection process.

Context and Timeline

This disclosure serves as a follow-up to the company's previous intimation dated 10th May, 2026 regarding the US FDA inspection at the same facility. The current communication confirms the successful closure of that inspection.